Velan Capital Investment Management LP - Q4 2022 holdings

$113 Million is the total value of Velan Capital Investment Management LP's 28 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 83.3% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRput$19,121,50050,000
+100.0%
16.89%
ADMA SellADMA BIOLOGICS INC$15,520,000
+21.2%
4,000,000
-24.1%
13.71%
+8.0%
IMCR SellIMMUNOCORE HLDGS PLCads$11,754,936
-14.6%
205,974
-29.8%
10.38%
-24.0%
TELA  TELA BIO INC$8,580,001
+35.0%
746,0870.0%7.58%
+20.2%
HZNP  HORIZON THERAPEUTICS PUB L$7,832,740
+83.9%
68,8290.0%6.92%
+63.8%
LNTH SellLANTHEUS HLDGS INC$7,644,000
-45.7%
150,000
-25.0%
6.75%
-51.6%
OPTN BuyOPTINOSE INC$6,469,193
-18.8%
3,496,861
+60.7%
5.72%
-27.7%
HRTX NewHERON THERAPEUTICS INC$6,250,0002,500,000
+100.0%
5.52%
QIPT  QUIPT HOME MEDICAL CORP$3,768,000
+12.9%
800,0000.0%3.33%
+0.6%
PNT NewPOINT BIOPHARMA GLOBAL INC$3,602,251494,136
+100.0%
3.18%
INSP NewINSPIRE MED SYS INC$2,518,80010,000
+100.0%
2.22%
THC NewTENET HEALTHCARE CORP$2,439,50050,000
+100.0%
2.16%
CTLT NewCATALENT INC$2,250,50050,000
+100.0%
1.99%
IMTX NewIMMATICS N.V$2,177,500250,000
+100.0%
1.92%
EDSA NewEDESA BIOTECH INC$1,919,998888,888
+100.0%
1.70%
HCSG SellHEALTHCARE SVCS GROUP INC$1,527,024
-68.4%
127,252
-68.2%
1.35%
-71.9%
 JASPER THERAPEUTICS INC$1,370,606
-38.8%
3,219,0360.0%1.21%
-45.5%
SGEN NewSEAGEN INC$1,285,10010,000
+100.0%
1.14%
CSU  SONIDA SENIOR LIVING INC$1,035,400
-23.0%
82,8320.0%0.92%
-31.4%
COLL BuyCOLLEGIUM PHARMACEUTICAL INC$1,031,194
+61.1%
44,448
+11.2%
0.91%
+43.5%
RZLT  REZOLUTE INC$828,000
-24.5%
400,0000.0%0.73%
-32.8%
BLU  BELLUS HEALTH INC NEW$822,000
-22.2%
100,0000.0%0.73%
-30.7%
XENE  XENON PHARMACEUTICALS INC$788,600
+9.2%
20,0000.0%0.70%
-2.7%
BuyALIMERA SCIENCES INC$698,511
-39.6%
257,753
+13.2%
0.62%
-46.2%
NewCONFORMIS INC$684,770206,256
+100.0%
0.60%
CHRS NewCOHERUS BIOSCIENCES INC$654,23282,605
+100.0%
0.58%
 LUMIRADX LTD$514,285
-11.8%
571,4280.0%0.45%
-21.5%
TERN NewTERNS PHARMACEUTICALS INC$108,37610,646
+100.0%
0.10%
GKOS ExitGLAUKOS CORP$0-6,896
-100.0%
-0.36%
ExitNYXOAH S A$0-79,021
-100.0%
-0.49%
ASRT ExitASSERTIO HOLDINGS INC$0-234,766
-100.0%
-0.53%
CFMS ExitCONFORMIS INC$0-5,156,406
-100.0%
-0.98%
ZYME ExitZYMEWORKS INC$0-234,902
-100.0%
-1.43%
ExitTHE ONCOLOGY INSTITUTE INC$0-548,841
-100.0%
-2.52%
BCRX ExitBIOCRYST PHARMACEUTICALS INC$0-225,000
-100.0%
-2.81%
FEZ ExitSPDR INDEX SHS FDSput$0-500,000
-100.0%
-15.26%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LANTHEUS HLDGS INC8Q3 202318.0%
ADMA BIOLOGICS INC8Q3 202313.7%
JASPER THERAPEUTICS INC8Q3 202317.8%
TELA BIO INC8Q3 20237.6%
REZOLUTE INC8Q3 20231.3%
OPTINOSE INC7Q3 20237.9%
IMMUNOCORE HLDGS PLC6Q1 202313.7%
ALIMERA SCIENCES INC6Q3 202334.0%
QUIPT HOME MEDICAL CORP6Q3 20234.8%
SONIDA SENIOR LIVING INC6Q1 20232.5%

View Velan Capital Investment Management LP's complete holdings history.

Latest filings
TypeFiled
SC 13G2024-03-28
13F-HR2024-02-14
42024-02-09
SC 13D/A2024-02-09
SC 13G/A2024-01-29
13F-HR2023-11-13
42023-10-04
42023-08-17
SC 13D/A2023-08-16
13F-HR2023-08-11

View Velan Capital Investment Management LP's complete filings history.

Export Velan Capital Investment Management LP's holdings